Alphaviruses, including Chikungunya (CHIKV) and Venezuelan equine encephalitis virus (VEEV), are among the leading causes of recurrent epidemics all over the world. Alphaviral nonstructural protein 1 (nsP1) orchestrates the capping of nascent viral RNA via its S-adenosyl methionine-dependent N-7-methyltransferase (MTase) and guanylyltransferase activities. Here, we developed and validated a novel capillary electrophoresis (CE)-based assay for measuring the MTase activity of purified VEEV and CHIKV nsP1. We employed the assay to assess the MTase inhibition efficiency of a few adenosine analogs and identified 5-iodotubercidin (5-IT) as an inhibitor of nsP1. The antiviral potency of 5-IT was evaluated in vitro using a combination of cell-based assays, which suggest that 5-IT is efficacious against CHIKV in cell culture (EC : 0.409 µm).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164056PMC
http://dx.doi.org/10.1002/1873-3468.13642DOI Listing

Publication Analysis

Top Keywords

inhibition chikungunya
4
chikungunya virus
4
virus adenosine
4
adenosine analog
4
analog targeting
4
targeting sam-dependent
4
nsp1
4
sam-dependent nsp1
4
nsp1 methyltransferase
4
methyltransferase alphaviruses
4

Similar Publications

The alphavirus chikungunya virus (CHIKV) is a serious human pathogen that can cause large-scale epidemics characterized by fever and joint pain and often resulting in chronic arthritis. Infection by alphaviruses including CHIKV and the closely related Semliki Forest virus (SFV) can induce the formation of filopodia-like intercellular long extensions (ILEs). ILEs emanate from an infected cell, stably attach to a neighboring cell, and mediate cell-to-cell viral transmission that is resistant to neutralizing antibodies.

View Article and Find Full Text PDF

4-Substituted-2-Thiazole Amides as Viral Replication Inhibitors of Alphaviruses.

J Med Chem

December 2024

Scientific Platforms Division, Southern Research, 2000 ninth Avenue South, Birmingham, Alabama 35205, United States.

2-(Methylthio)--(4-(naphthalen-2-yl)thiazol-2-yl)nicotinamide was identified as an inhibitor against Chikungunya virus (CHIKV) with good antiviral activity [EC = 0.6 μM; EC = 0.93 μM and viral titer reduction (VTR) of 6.

View Article and Find Full Text PDF

The potential inhibitory mechanism of EGCG against the Chikungunya virus targeting non-structural protein 2 through molecular dynamics simulation.

Sci Rep

November 2024

Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, 00014, Helsinki, Finland.

This study explores the potential of Indonesian herbal compounds against the chikungunya virus (CHIKV), which causes widespread illness without a specific cure known as chikungunya fever (CHIKF). By focusing on the nsP2 protein, crucial for the virus's replication, the research utilizes computational methods identifying inhibitor compounds with high binding affinity. These promising candidates are further analyzed through 1 µs of molecular dynamic (MD) simulation studies, aiming to find effective inhibitors to control the chikungunya spread, leveraging Indonesia's rich biodiversity for novel anti-CHIKV therapies.

View Article and Find Full Text PDF

RA-0003022 () was identified as a high-quality covalent chemical probe for nsP2 cysteine protease (nsP2pro). Isoxazole covalently captured the active site C478 and inactivated the enzyme with a / ratio of 6000 Ms. A negative control analog RA-0025453 () retained the covalent warhead but demonstrated >100-fold decrease in enzyme inhibition.

View Article and Find Full Text PDF

Evolution of antiviral resistance captures a transient interdomain functional interaction between chikungunya virus envelope glycoproteins.

bioRxiv

November 2024

Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín (UNSAM) - Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), San Martín B1650, Argentina.

Article Synopsis
  • Envelope proteins, specifically the E1 and E2 proteins of the Chikungunya virus (CHIKV), drive the fusion of the virus with host cell membranes, allowing the virus to enter cells.
  • Research on CHIKV has shown that mutations in these proteins can confer resistance to antiviral treatments by enhancing fusion capabilities, particularly a double-mutant strain that tolerates a higher pH for effective fusion.
  • Molecular dynamics simulations suggest that interactions between specific residues in these envelope proteins are crucial for their rearrangement during the fusion process, revealing important insights into viral infection mechanisms and potential therapeutic targets.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!